Sfoglia per Autore
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity.
2002-01-01 MICHIELI P; CAVASSA S; BASILICO C; DE LUCA A; MAZZONE M; ASTI C; CHIUSAROLI R; GUGLIELMI M; BOSSU' P; COLOTTA F; CASELLI G; PM COMOGLIO
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.
2003-01-01 S. PENNACCHIETTI; P. MICHIELI; M. GALLUZZO; M. MAZZONE; S. GIORDANO; P. COMOGLIO
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor
2004-01-01 MICHIELI P; MAZZONE M; BASILICO C; CAVASSA S; SOTTILE A; NALDINI L; P. COMOGLIO
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice
2004-01-01 MAZZONE M; BASILICO C; CAVASSA S; PENNACCHIETTI S; RISIO M; NALDINI L; PM COMOGLIO; MICHIELI P
The Met pathway: master switch and drug target in cancer progression
2006-01-01 MAZZONE M; P. COMOGLIO
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity
2006-01-01 PETRELLI A; CIRCOSTA P; GRANZIERO L; MAZZONE M; PISACANE A; FENOGLIO S; COMOGLIO P; GIORDANO S
Genetic targeting of the kinase activity of the Met receptor in cancer cells
2007-01-01 S. ARENA; A. PISACANE; M. MAZZONE; P.M. COMOGLIO; A. BARDELLI
Building in resistance to endothelial cell death
2007-01-01 Mazzone M.; De Almodovar C.R.; Carmeliet P.
The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo
2007-01-01 BARDELLA C; DETTORI D; OLIVERO M; COLTELLA N; MAZZONE M; DI RENZO MF
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
2007-01-01 Fischer C.; Jonckx B.; Mazzone M.; Zacchigna S.; Loges S.; Pattarini L.; Chorianopoulos E.; Liesenborghs L.; Koch M.; De Mol M.; Autiero M.; Wyns S.; Plaisance S.; Moons L.; van Rooijen N.; Giacca M.; Stassen J.-M.; Dewerchin M.; Collen D.; Carmeliet P.
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis
2008-01-01 Takahara T; Xue F; Mazzone M; Yata Y; Nonome K; Kanayama M; Kawai K; Pisacane AM; Takahara S; Li XK; Comoglio PM; Sugiyama T; Michieli P
Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism
2008-01-01 Aragones J.; Schneider M.; Van Geyte K.; Fraisl P.; Dresselaers T.; Mazzone M.; Dirkx R.; Zacchigna S.; Lemieux H.; Jeoung N.H.; Lambrechts D.; Bishop T.; Lafuste P.; Diez-Juan A.; Harten S.K.; Van Noten P.; De Bock K.; Willam C.; Tjwa M.; Grosfeld A.; Navet R.; Moons L.; Vandendriessche T.; Deroose C.; Wijeyekoon B.; Nuyts J.; Jordan B.; Silasi-Mansat R.; Lupu F.; Dewerchin M.; Pugh C.; Salmon P.; Mortelmans L.; Gallez B.; Gorus F.; Buyse J.; Sluse F.; Harris R.A.; Gnaiger E.; Hespel P.; Van Hecke P.; Schuit F.; Van Veldhoven P.; Ratcliffe P.; Baes M.; Maxwell P.; Carmeliet P.
"Active" cancer immunotherapy by anti-Met antibody gene transfer
2008-01-01 Vigna E; Pacchiana G; Mazzone M; Chiriaco C; Fontani L; Basilico C; Pennacchietti S; Comoglio PM
The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment
2008-01-01 Rolny C; Capparuccia L; Casazza A; Mazzone M; Vallario A; Cignetti A; Medico E; Carmeliet P; Comoglio PM; Tamagnone L.
Drug discovery: A lifeline for suffocating tissues
2008-01-01 Mazzone M.; Carmeliet P.
FLT1 and its ligands VEGFB and PlGF: Drug targets for anti-angiogenic therapy?
2008-01-01 Fischer C.; Mazzone M.; Jonckx B.; Carmeliet P.
Role and therapeutic potential of VEGF in the nervous system
2009-01-01 De Almodovar C.R.; Lambrechts D.; Mazzone M.; Carmeliet P.
Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.
2009-01-01 Mazzone M; Dettori D; Leite de Oliveira R; Loges S; Schmidt T; Jonckx B; Tian YM; Lanahan AA; Pollard P; Ruiz de Almodovar C; De Smet F; Vinckier S; Aragonés J; Debackere K; Luttun A; Wyns S; Jordan B; Pisacane A; Gallez B; Lampugnani MG; Dejana E; Simons M; Ratcliffe P; Maxwell P; Carmeliet P.
Regulation of Angiogenesis by Oxygen and Metabolism
2009-01-01 Fraisl P.; Mazzone M.; Schmidt T.; Carmeliet P.
Branching morphogenesis and antiangiogenesis candidates: Tip cells lead the way
2009-01-01 Carmeliet P.; De Smet F.; Loges S.; Mazzone M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity. | 2002 | MICHIELI P; CAVASSA S; BASILICO C; DE LUCA A; MAZZONE M; ASTI C; CHIUSAROLI R; GUGLIELMI M; BOSSU' P; COLOTTA F; CASELLI G; PM COMOGLIO | |
| Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. | 2003 | S. PENNACCHIETTI; P. MICHIELI; M. GALLUZZO; M. MAZZONE; S. GIORDANO; P. COMOGLIO | |
| Targeting the tumor and its microenvironment by a dual-function decoy Met receptor | 2004 | MICHIELI P; MAZZONE M; BASILICO C; CAVASSA S; SOTTILE A; NALDINI L; P. COMOGLIO | |
| An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice | 2004 | MAZZONE M; BASILICO C; CAVASSA S; PENNACCHIETTI S; RISIO M; NALDINI L; PM COMOGLIO; MICHIELI P | |
| The Met pathway: master switch and drug target in cancer progression | 2006 | MAZZONE M; P. COMOGLIO | |
| Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity | 2006 | PETRELLI A; CIRCOSTA P; GRANZIERO L; MAZZONE M; PISACANE A; FENOGLIO S; COMOGLIO P; GIORDANO S | |
| Genetic targeting of the kinase activity of the Met receptor in cancer cells | 2007 | S. ARENA; A. PISACANE; M. MAZZONE; P.M. COMOGLIO; A. BARDELLI | |
| Building in resistance to endothelial cell death | 2007 | Mazzone M.; De Almodovar C.R.; Carmeliet P. | |
| The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo | 2007 | BARDELLA C; DETTORI D; OLIVERO M; COLTELLA N; MAZZONE M; DI RENZO MF | |
| Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels | 2007 | Fischer C.; Jonckx B.; Mazzone M.; Zacchigna S.; Loges S.; Pattarini L.; Chorianopoulos E.; Liesenborghs L.; Koch M.; De Mol M.; Autiero M.; Wyns S.; Plaisance S.; Moons L.; van Rooijen N.; Giacca M.; Stassen J.-M.; Dewerchin M.; Collen D.; Carmeliet P. | |
| Metron factor-1 prevents liver injury without promoting tumor growth and metastasis | 2008 | Takahara T; Xue F; Mazzone M; Yata Y; Nonome K; Kanayama M; Kawai K; Pisacane AM; Takahara S; Li XK; Comoglio PM; Sugiyama T; Michieli P | |
| Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism | 2008 | Aragones J.; Schneider M.; Van Geyte K.; Fraisl P.; Dresselaers T.; Mazzone M.; Dirkx R.; Zacchigna S.; Lemieux H.; Jeoung N.H.; Lambrechts D.; Bishop T.; Lafuste P.; Diez-Juan A.; Harten S.K.; Van Noten P.; De Bock K.; Willam C.; Tjwa M.; Grosfeld A.; Navet R.; Moons L.; Vandendriessche T.; Deroose C.; Wijeyekoon B.; Nuyts J.; Jordan B.; Silasi-Mansat R.; Lupu F.; Dewerchin M.; Pugh C.; Salmon P.; Mortelmans L.; Gallez B.; Gorus F.; Buyse J.; Sluse F.; Harris R.A.; Gnaiger E.; Hespel P.; Van Hecke P.; Schuit F.; Van Veldhoven P.; Ratcliffe P.; Baes M.; Maxwell P.; Carmeliet P. | |
| "Active" cancer immunotherapy by anti-Met antibody gene transfer | 2008 | Vigna E; Pacchiana G; Mazzone M; Chiriaco C; Fontani L; Basilico C; Pennacchietti S; Comoglio PM | |
| The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment | 2008 | Rolny C; Capparuccia L; Casazza A; Mazzone M; Vallario A; Cignetti A; Medico E; Carmeliet P; Comoglio PM; Tamagnone L. | |
| Drug discovery: A lifeline for suffocating tissues | 2008 | Mazzone M.; Carmeliet P. | |
| FLT1 and its ligands VEGFB and PlGF: Drug targets for anti-angiogenic therapy? | 2008 | Fischer C.; Mazzone M.; Jonckx B.; Carmeliet P. | |
| Role and therapeutic potential of VEGF in the nervous system | 2009 | De Almodovar C.R.; Lambrechts D.; Mazzone M.; Carmeliet P. | |
| Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. | 2009 | Mazzone M; Dettori D; Leite de Oliveira R; Loges S; Schmidt T; Jonckx B; Tian YM; Lanahan AA; Pollard P; Ruiz de Almodovar C; De Smet F; Vinckier S; Aragonés J; Debackere K; Luttun A; Wyns S; Jordan B; Pisacane A; Gallez B; Lampugnani MG; Dejana E; Simons M; Ratcliffe P; Maxwell P; Carmeliet P. | |
| Regulation of Angiogenesis by Oxygen and Metabolism | 2009 | Fraisl P.; Mazzone M.; Schmidt T.; Carmeliet P. | |
| Branching morphogenesis and antiangiogenesis candidates: Tip cells lead the way | 2009 | Carmeliet P.; De Smet F.; Loges S.; Mazzone M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile